Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2016 Feb 18

PMID 26885530

Citations 24

Authors

Uazman Alam

Yasar Amjad

Anges Wan Shan Chan

Omar Asghar

Ioannis N Petropoulos

Rayaz A Malik

Affiliations

Soon will be listed here.

Abstract

Background: Experimental and clinical studies suggest a possible association between vitamin D deficiency and both diabetic retinopathy and maculopathy.

Methods: We have performed a cross-sectional study in adults with types 1 and 2 diabetes mellitus. The relationship between the presence and severity of diabetic retinopathy and maculopathy with serum 25-hydroxyvitamin D concentration was evaluated using logistic regression analyses in the presence of demographic and clinical covariates.

Results: 657 adults with diabetes were stratified based on retinopathy grading: No Diabetic Retinopathy (39%), Background Diabetic Retinopathy (37%), Preproliferative Diabetic Retinopathy (21%), and Proliferative Diabetic Retinopathy (3%), respectively. There were no differences in serum 25-hydroxyvitamin D concentrations (25(OH)D) between the groups (15.3 ± 9.0 versus 16.4 ± 10.5 versus 15.9 ± 10.4 versus 15.7 ± 8.5 ng/mL, P = NS). Logistic regression analysis demonstrated no statistically significant relationship between the severity of retinopathy and serum 25(OH)D. Furthermore, there was no difference in serum 25(OH)D between those with (n = 94, 14%) and those without (n = 563, 86%) Diabetic Maculopathy (16.2 ± 10.0 versus 15.8 ± 9.8, P = NS) and no relationship was demonstrated by logistic regression analyses between the two variables.

Conclusions: This study has found no association between serum 25(OH)D and the presence and severity of diabetic retinopathy or maculopathy.

Citing Articles

Vitamin D Deficiency as a Risk Factor for Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Petrea C, Ghenciu L, Iacob R, Stoicescu E, Sandesc D Biomedicines. 2025; 13(1).

PMID: 39857652 PMC: 11762121. DOI: 10.3390/biomedicines13010068.

Vitamin D Supplementation: Shedding Light on the Role of the Sunshine Vitamin in the Prevention and Management of Type 2 Diabetes and Its Complications.

Vasdeki D, Tsamos G, Dimakakos E, Patriarcheas V, Koufakis T, Kotsa K Nutrients. 2024; 16(21).

PMID: 39519484 PMC: 11547801. DOI: 10.3390/nu16213651.

Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis.

Fan S, Shi X, Li X, Li J, Yu S Front Med (Lausanne). 2024; 11:1431170.

PMID: 39444820 PMC: 11496056. DOI: 10.3389/fmed.2024.1431170.

Vitamin D deficiency and the risk of diabetic retinopathy in patients with type 2 diabetes in Tibet: a cross-sectional analysis.

Chen C, Meng S, Wu X, Ciren W, Shen J, Zeding Z BMC Endocr Disord. 2024; 24(1):139.

PMID: 39095726 PMC: 11295715. DOI: 10.1186/s12902-024-01668-4.

Assessment of vitamin D status and vitamin D receptor polymorphism in Egyptian children with Type 1 diabetes.

Mostafa E, Abo Hashish M, Ismail N, Hasanin H, Hasanin R, Wahby A J Genet Eng Biotechnol. 2024; 22(1):100343.

PMID: 38494252 PMC: 10980865. DOI: 10.1016/j.jgeb.2023.100343.

References

Zoppini G, Galletti A, Targher G, Brangani C, Pichiri I, Trombetta M . Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2015; 3(1):e000058. PMC: 4410134. DOI: 10.1136/bmjdrc-2014-000058. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Kaur H, Donaghue K, Chan A, Benitez-Aguirre P, Hing S, Lloyd M . Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care. 2011; 34(6):1400-2. PMC: 3114351. DOI: 10.2337/dc11-0103. View

Albert D, Scheef E, Wang S, Mehraein F, Darjatmoko S, Sorenson C . Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48(5):2327-34. DOI: 10.1167/iovs.06-1210. View

Patra S, Gomm E, Macipe M, Bailey C . Interobserver agreement between primary graders and an expert grader in the Bristol and Weston diabetic retinopathy screening programme: a quality assurance audit. Diabet Med. 2009; 26(8):820-3. DOI: 10.1111/j.1464-5491.2009.02767.x. View

Bunce C, Wormald R . Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health. 2006; 6:58. PMC: 1420283. DOI: 10.1186/1471-2458-6-58. View

Aksoy H, Akcay F, Kurtul N, Baykal O, Avci B . Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem. 2000; 33(1):47-51. DOI: 10.1016/s0009-9120(99)00085-5. View

Ismail-Beigi F, Craven T, OConnor P, Karl D, Calles-Escandon J, Hramiak I . Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int. 2011; 81(6):586-94. PMC: 4641306. DOI: 10.1038/ki.2011.415. View

Harindhanavudhi T, Mauer M, Klein R, Zinman B, Sinaiko A, Caramori M . Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control. Diabetes Care. 2011; 34(8):1838-42. PMC: 3142059. DOI: 10.2337/dc11-0476. View

10.

Taverna M, Selam J, Slama G . Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab. 2005; 90(8):4803-8. DOI: 10.1210/jc.2004-2407. View

11.

Craig T, Sommer S, Sussman C, Grande J, Kumar R . Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio. J Bone Miner Res. 2008; 23(9):1486-96. PMC: 2575117. DOI: 10.1359/jbmr.080403. View

12.

Bucan K, Ivanisevic M, Zemunik T, Boraska V, Skrabic V, Vatavuk Z . Retinopathy and nephropathy in type 1 diabetic patients--association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL-1 receptor 1 genes. Coll Antropol. 2010; 33 Suppl 2:99-105. View

13.

Alam U, Najam O, Al-Himdani S, Benoliel S, Jinadev P, Berry J . Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia. Diabet Med. 2012; 29(10):1343-5. DOI: 10.1111/j.1464-5491.2012.03692.x. View

14.

Patrick P, Visintainer P, Shi Q, Weiss I, Brand D . Vitamin D and retinopathy in adults with diabetes mellitus. Arch Ophthalmol. 2012; 130(6):756-60. DOI: 10.1001/archophthalmol.2011.2749. View

15.

Hammes H, Feng Y, Pfister F, Brownlee M . Diabetic retinopathy: targeting vasoregression. Diabetes. 2011; 60(1):9-16. PMC: 3012202. DOI: 10.2337/db10-0454. View

16.

Joergensen C, Hovind P, Schmedes A, Parving H, Rossing P . Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011; 34(5):1081-5. PMC: 3114500. DOI: 10.2337/dc10-2459. View

17.

Resnikoff S, Pascolini D, Etyaale D, Kocur I, Pararajasegaram R, Pokharel G . Global data on visual impairment in the year 2002. Bull World Health Organ. 2005; 82(11):844-51. PMC: 2623053. DOI: /S0042-96862004001100009. View

18.

Engelen L, Schalkwijk C, Eussen S, Scheijen J, Soedamah-Muthu S, Chaturvedi N . Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Cardiovasc Diabetol. 2015; 14:67. PMC: 4456046. DOI: 10.1186/s12933-015-0231-2. View

19.

Ireland R . Diabetic nephropathy: Paricalcitol lowers residual albuminuria in type 2 diabetes. Nat Rev Nephrol. 2011; 7(2):62. DOI: 10.1038/nrneph.2010.183. View

20.

Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M . 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis. 2008; 204(1):85-9. DOI: 10.1016/j.atherosclerosis.2008.08.020. View